mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.

Explore mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential applications.

Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna to advance mRNA vaccines and therapeutics. Scientists can select any protein in the human proteome to be engineered or they can design novel proteins.

Mar 26, 2024 · mRNA-1283 induced a more robust immune response compared to Spikevax ® COVID-19 vaccine, mRNA-1273.222. Next-generation mRNA vaccine design offers the potential of longer shelf life and storage advantages, and paves the way for combination vaccine against influenza and COVID-19, mRNA-1083

Learn more about the science behind mRNA and how Moderna's scientists are researching and developing investigational mRNA medicines to potentially help prevent or treat disease.

Moderna’s goal is to explore the potential of messenger RNA (mRNA) science to help create a new generation of medicines for patients.

Mar 27, 2024 · Moderna's VZV vaccine candidate mRNA-1468 has initial data available from a Phase 1/2 trial, which was designed to test safety and immunogenicity in healthy adults 50 years of age and older in the U.S. The randomized 1:1:1:1:1, observer-blind, active-controlled study of mRNA-1468 elicited strong antigen-specific T cell responses at one month ...

Nov 7, 2024 · Moderna intends to file in 2024 for approval of its next-generation COVID-19 vaccine (mRNA-1283) and RSV vaccine (mRNA-1345) for high-risk adults aged 18-59; the Company expects to communicate the PDUFA date for each of …

mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.

Aug 14, 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.